Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis Shifts Focus to Rare Diseases
Novartis Shifts Focus to Rare Diseases
Novartis Shifts Focus to Rare Diseases
Submitted by
admin
on December 21, 2009 - 9:34am
Source:
WSJ Online
News Tags:
Novartis
Daniel Vasella
Pharma CEOs
Headline:
Novartis Shifts Focus to Rare Diseases
Do Not Allow Advertisers to Use My Personal information
